(Q34995971)

5 August 2017

1 reference

title

New approaches to hematopoietic cell transplantation for hematological diseases in children (English)

1 reference

5 August 2017

2

Bertram Lubin

0 references

author name string

Paul Woodard

series ordinal

1

1 reference

5 August 2017

C Mark C Walters

series ordinal

3

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Pediatric Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

49

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

989-1007

1 reference

Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Bone marrow transplantation for sickle cell disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Mixed chimerism: preclinical studies and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Nonmyeloablative hematopoietic cell transplant for treatment of immune deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Successful hematopoietic reconstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond-Blackfan anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Umbilical cord blood for allogeneic transplantation in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

The potential role of rapamycin in pediatric transplantation as observed from adult studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

Immune recovery and immunotherapy after stem cell transplantation in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900026-3

10.1016/S0031-3955(02)00026-3

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference